Hypertension News

Hypertension in adolescence was associated with a significantly increased risk for end-stage renal disease, according to a study published in JAMA Internal Medicine.

Acute declines in renal function during intense lowering of blood pressure can not only hasten the kidney’s demise but is also associated with a higher risk of patient mortality in some cases, a study shows.

Two sham-controlled trials demonstrating the efficacy of renal denervation presented at EuroPCR have rekindled hope for the technology as a treatment for hypertension.

According to data published in the Clinical Journal of the American Society of Nephrology, researchers found a high prevalence of hypertension in children with autosomal dominant polycystic kidney disease.

Living kidney donors with end-stage renal disease had a lower mortality rate compared to matched non-donors, according to a study that will appear in the Kidney International Reports.

AUSTIN, Texas — At the National Kidney Foundation Spring Clinical Meetings, Matthew R. Weir, MD, spoke about results of a study that measured the efficacy and safety of Veltassa for patients with hyperkalemia.

Medtronic announced that the FDA has issued an investigational device exemption allowing the company to begin a randomized, sham-controlled pivotal trial to evaluate a renal denervation system in patients with hypertension.

Intensive systolic blood pressure (SBP) lowering may prevent more than 100,000 deaths in the United States each year, according to a study presented at ASN Kidney Week 2016 November 15-20 in Chicago.

A new study indicates that maintaining an intermediate level of high density lipoprotein cholesterol (HDL-C) may help people live longer. The study, which appears in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN), found that both low and high HDL-C levels were linked with a higher risk of premature death. Also, intermediate HDL-C levels were associated with a lower risk of death across all levels of kidney function.

Strict blood pressure control in patients with chronic kidney disease may help protect against premature death, according to a recent analysis of clinical trial data published in the Journal of the American Society of Nephrology (JASN).